Replies to post #212880 on Innovation Pharmaceuticals Inc (IPIX)

[JTORENCE]

Thanks cabel. Looks like there was some progress from the conference:

"We had multiple meetings in San Francisco and believe pharmas view us as the leaders in the race for a drug to prevent SOM."

[govorchin]

So by Leo answering you I assume no deal as yet.

[Jhawker]

Dammit Cabel! Why do you keep doing such a great job refuting the negative posts?! ;)

[LilyGDog]

Thank you cabel, "believe pharmas view us as the leaders in the race for a drug to prevent SOM" That's great. I can't wait to see how this plays out.

Go Leo & IPIX!

Funny you should ask,...

Just got this back from Leo after I sent him a link to the article PP posted.

They did a much larger trial. Their patients were dosed by infusion multiple times a week for a number of hours. Obviously a huge disadvantage to our brilacidin rinse. We are not concerned. You can't disregard their placebo arm SOM percentage which was slightly lower than ours. In addition they reported "in the overall incidence of SOM through 60 Gy of radiation" We reported "cumulative radiation dose criteria of at least 55 Gy—the minimum treatment threshold for inclusion in the efficacy population." So we made it more challenging for ourselves by using the lower number of 55GY.

We had multiple meetings in San Francisco and believe pharmas view us as the leaders in the race for a drug to prevent SOM.

[Amatuer17]

Was today’s PR a reaction to results from G and your communication with Leo?

He did not issue any PR after the conf, did not think it was important to mention -“and they are what triggered a newfound flurry of inbound partnership discussions at the San Francisco conferences,””

Seems he did want to be left behind and issued a PR with audio.

It clearly seems a reactionary PR and market gave it a pass